Rare diseases
Investigational molecules
Locations
296 conditions with trials, the busiest first
591 trials across Europe, recruiting first
Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer
BelgiumStudy on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes
BelgiumStudy on the Long-Term Safety and Effects of OMS906 for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
GermanyStudy on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury
AustriaStudy of ONCOFID-P-B for Patients with Bladder Carcinoma in Situ Unresponsive to BCG Treatment
FranceStudy of erdafitinib versus chemotherapy (gemcitabine or mitomycin) for patients with high-risk non-muscle-invasive bladder cancer with FGFR mutations who failed BCG therapy
FranceStudy Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment
BelgiumStudy on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery
BelgiumStudy on the Safety and Effectiveness of Padeliporfin Therapy for Patients with Low-Grade Upper Tract Urothelial Cancer
AustriaStudy on Anifrolumab for Adults with Active Lupus Nephritis
BelgiumStudy of TYRA-300 for Patients with Advanced Bladder Cancer and Other Solid Tumors with FGFR3 Gene Changes
FranceStudy on Vemircopan for Adults with Lupus Nephritis or IgA Nephropathy
GermanyThe therapies tested most often in Renal and urinary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
